Sana Biotechnology Stock Analysis

SANA -  USA Stock  

USD 23.52  1.14  5.09%

The current slip in stock price created some momentum for investors as it was traded today as low as 22.25 and as high as 23.69 per share. The company directors and management have failed to build on market volatilities in May. However, diversifying your overall positions with Sana Biotechnology may protect your principal portfolio during upcoming market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.67. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Sana Biotechnology partners.
Additionally, take a look at World Market Map.

Search Stock Analysis 

 
Refresh
The Sana Biotechnology stock analysis report makes it easy to digest most publicly released information about Sana Biotechnology and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Sana Biotechnology stock analysis module also helps to analyze the Sana Biotechnology price relationship with some important fundamental indicators such as market cap and management efficiency.

Sana Biotechnology Stock Analysis Notes

The company had not issued any dividends in recent years. Sana Biotechnology, Inc. develops and delivers engineered cells as medicine for patients. The company was founded in 2018 and is based in Seattle, Washington with additional offices in South San Francisco, California and Cambridge, Massachusetts. Sana Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. To find out more about Sana Biotechnology contact the company at 206 701 7914 or learn more at http://sana.com.

Sana Biotechnology Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Sana Biotechnology's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Sana Biotechnology or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Sana Biotechnology generates negative expected return over the last 90 days
Sana Biotechnology has high historical volatility and very poor performance
Net Loss for the year was (215.18 M).
Sana Biotechnology currently holds about 138.98 M in cash with (134.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.75.
Latest headline from www.equities.com: Sana Biotechnology Inc gains 4.7110 percent for June 14 - Equities.com

Sana Biotechnology Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Sana Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sana Biotechnology backward and forwards among themselves. Sana Biotechnology's institutional investor refers to the entity that pools money to purchase Sana Biotechnology's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Flagship Pioneering IncCommon Shares34.2 M1.1 B
Canada Pension Plan Investment BoardCommon Shares10.2 M340.6 M
Baillie Gifford CoCommon Shares10 M334.3 M
Fmr LlcCommon Shares8.7 M292.4 M
Public Sector Pension Investment BoardCommon Shares4.1 M138.3 M
Sb Management LtdCommon Shares2.6 M87.9 M
Vanguard Group IncCommon Shares2.3 M77.9 M
Note, although Sana Biotechnology's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Sana Biotechnology Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 7.47 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sana Biotechnology's market, we take the total number of its shares issued and multiply it by Sana Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

Sana Biotechnology management efficiency ratios could be used to measure how well sana biotechnology manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 17th of June 2021, Sana Biotechnology has the coefficient of variation of (1,693), and Risk Adjusted Performance of (0.028311). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sana Biotechnology, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Sana Biotechnology, which can be compared to its competition. Please validate Sana Biotechnology treynor ratio, as well as the relationship between the potential upside and expected short fall to decide if Sana Biotechnology is priced more or less accurately, providing market reflects its prevalent price of 23.52 per share. Given that Sana Biotechnology has jensen alpha of (0.26), we advise you to double-check Sana Biotechnology's current market performance to make sure the company can sustain itself at a future point.

Sana Biotechnology Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Exponential Moving Average is calculated by weighting recent values of Sana Biotechnology more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Sana Biotechnology Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sana Biotechnology insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sana Biotechnology's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sana Biotechnology insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Sana Biotechnology Predictive Daily Indicators

Sana Biotechnology intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Sana Biotechnology stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Sana Biotechnology Forecast Models

Sana Biotechnology time-series forecasting models is one of many Sana Biotechnology's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sana Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Sana Biotechnology Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Sana Biotechnology stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sana Biotechnology shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Sana Biotechnology. By using and applying Sana Biotechnology Stock analysis, traders can create a robust methodology for identifying Sana Biotechnology entry and exit points for their positions.
Sana Biotechnology, Inc. develops and delivers engineered cells as medicine for patients. The company was founded in 2018 and is based in Seattle, Washington with additional offices in South San Francisco, California and Cambridge, Massachusetts. Sana Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Sana Biotechnology to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Aroon Oscillator Now

   

Aroon Oscillator

Analyze current equity momentum using Aroon Oscillator and other momentum ratios
All  Next Launch Module
Additionally, take a look at World Market Map. Note that the Sana Biotechnology information on this page should be used as a complementary analysis to other Sana Biotechnology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Sana Biotechnology Stock analysis

When running Sana Biotechnology stock analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's stock examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Equity Search
Search for activelly-traded equities including funds and ETFs from over 30 global markets
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
The market value of Sana Biotechnology is measured differently than its book value, which is the value of Sana Biotechnology that is recorded on the company's balance sheet. Investors also form their own opinion of Sana Biotechnology stock's value that differs from its market value or its book value, called intrinsic value, which is Sana Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sana Biotechnology's market value can be influenced by many factors that don't directly affect Sana Biotechnology underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sana Biotechnology's stock value and its price as these two are different measures arrived at by different means. Investors typically determine Sana Biotechnology value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sana Biotechnology's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.